Ruxolitinib phosphate is a phosphate salt of ruxolitinib, formed by reacting ruxolitinib with one equivalent of phosphoric acid. It functions as a non-specific protein-tyrosine kinase inhibitor and is used as an antineoplastic agent in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1092939-17-7
Ruxolitinib hydrochloride
pharmaceutical raw material
Ruxolitinib
pharmaceutical raw material
(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile maleate
research compound
(3R,5R)-Rosuvastatin
pharmaceutical raw material
Methadone hydrochloride
pharmaceutical raw material
4-(2-(Benzyl(methyl)amino)-1-hydroxyethyl)benzene-1,2-diol
pharmaceutical raw material
Cis-loperamide oxide
pharmaceutical raw material
Deuruxolitinib phosphate
pharmaceutical raw material
(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile;phosphoric acid
JFMWPOCYMYGEDM-XFULWGLBSA-N
C1CCC(C1)[C@@H](CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O